Continuous Addition of Adenosine with a Micropump System Improves Warm Whole Blood Cardioplegia
DOI:
https://doi.org/10.1532/hsf.572Abstract
Background: Micropump additive systems allow for continuous modification of cardioplegia composition during heart surgery. Although the use of such systems in warm heart surgery is theoretically desirable, the role of the systems has been clinically limited by coronary vasoreactivity with higher potassium concentration and unreliable mechanical arrest at lower potassium concentration. Adenosine, a potent coronary vasodilator and arresting agent, has the potential to reduce the potassium concentration required for arrest and to improve distribution of cardioplegia. However, clinical use of adenosine has been limited by a short half-life in blood and difficulty in titrating the dose. This study tested the hypothesis that continuous addition of adenosine with an in-line linear micropump system would facilitate whole blood hyperkalemic perfusion for cardiac surgery.
Methods: Canine hearts (n = 9) were randomized to 20 minutes of arrest with whole blood cardioplegia or cardioplegia with adenosine at either low (0.5 3M) or high (8 3M) concentration. Potassium was supplemented at an arresting dose (24 mEq/L) for 5 minutes and then at a maintenance dose (6 mEq/L) for an additional 15 minutes. Coronary flow was held constant (4 mL/kg per minute), and aortic root pressure was measured. Myocardial performance was assessed by measurement of the end-diastolic pressure to stroke volume relationship at constant afterload. Myocardial tissue perfusion was evaluated with colored microspheres.
Results: During the initial period of high-concentration potassium arrest, coronary resistance rose progressively regardless of adenosine addition. Coronary resistance remained elevated during the period of low potassium perfusion, except when high-concentration adenosine was added. With addition of 8 3M adenosine, coronary resistance returned to baseline, and left ventricular endocardial perfusion was augmented. Electromechanical quiescence improved with adenosine perfusion and was complete with high-dose adenosine addition. Function was preserved in all hearts.
Conclusion: Use of a modern micropump system allowed for continuous addition of adenosine and potassium to whole blood cardioplegia. Adenosine minimized potassium-induced coronary vasoconstriction and improved endocardial perfusion and mechanical quiescence. These findings supported addition of adenosine to the perfusate during warm whole blood cardioplegia.
References
Berne RM. 1980. The role of adenosine in the regulation of coronary blood flow. Circ Res 47:807-17.nBolling SF, Bies LE, Gallagher KP, et al. 1989. Enhanced myocardial protection with adenosine. Ann Thorac Surg 47:809-15.nCannon MB, Vine AJ, Kantor HL, et al. 1994. Warm and cold blood cardioplegia: comparison of myocardial function and metabolism using 31p magnetic resonance spectroscopy. Circulation 90:II328-38.nClaude RE. 1983. Dipyridamole inhibition of adenosine metabolism in human blood. Eur J Pharmacol 93:21-6.nCohen G, Feder-Elituv R, Iazetta J, et al. 1998. Phase 2 studies of adenosine cardioplegia. Circulation 98:II225-33.nDaggett WM, Nugent GC, Carr PW, et al. 1967. Influence of vagal stimulation on ventricular contractility, O consumption and coronary flow. Am J Physiol 212:8-18.nDiMarco JP, Sellers TD, Berne RM, et al. 1983. Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia. Circulation 68:1254-63.nDobson JG Jr. 1983. Adenosine reduces catecholamine contractile responses in oxygenated and hypoxic atria. Am J Physiol 245:H468-74.nEly SW, Mentzer RM Jr, Lasley RD, et al. 1985. Functional and metabolic evidence of enhanced myocardial tolerance to ischemia and reperfusion with adenosine. J Thorac Cardiovasc Surg 90:549-56.nFollette D, Fey K, Becker H, et al. 1980. Superiority of blood cardioplegia over asanguinous cardioplegia: an experimental and clinical study. Chir Forum Exp Klin Forsch 279-83.nFremes SE, Levy SL, Christakis GT, et al. 1996. Phase I human trial of adenosine-potassium cardioplegia. Circulation 94:370-5.nGeffin AG, O'Keefe DD, Denenberg AG, et al. 1987. Microsphere reference flow samples during systemic flow adjustment. Am J Physiol 252:H851-6.nGuyton RA, Gott JP. 1995. A critical evaluation of warm blood cardioplegia. In: Salerno TA, ed. Warm heart surgery. London: Edward Arnold Press. p 168-77.nHe GW, Yang CQ. 1996. Hyperkalemia alters endothelium-dependent relaxation through non-nitric oxide and noncyclooxygenase pathway: a mechanism for coronary dysfunction due to cardioplegia. Ann Thorac Surg 61:1394-9.nHearse DJ, Stewart DA, Braimbridge MV. 1975. Hypothermic arrest and potassium arrest, metabolic and myocardial protection during elective cardiac arrest. Circ Res 36:481-9.nMaddali MM, Reddy JD, Krishnaswami S. 2000. Adenosine as an adjunct to inducing rapid asystole during cardioplegic arrest. Indian Heart J 52:434-7.nMenasche P. 1996. Blood cardioplegia: do we still need to dilute? Ann Thorac Surg 62:957-60.nMorrison RR, Talkuder MAH, Ledent C, et al. 2002. Cardiac effects of adenosine A receptor knockout hearts: uncovering A receptors. Am J Physiol 282:H437-44.nMoser GH, Schrader J, Deuce A. 1989. Turnover of adenosine in plasma of human and dog blood. Am J Physiol 256:C799-806.nOlsson RA, Davis CJ, Khouri EM, Patterson RE. 1976. Evidence for an adenosine receptor on the surface of dog coronary myocytes. Circ Res 39:93-8.nRescigno G, Nataf P, Raffoul R. 1998. Continuous warm blood cardioplegia pitfalls. Heart Surg Forum 1:142-5.nSatyanarayana PV, Rao PS, Rao KM, et al. 1992. Continuous normothermic cardioplegia: simplified delivery circuit. Ann Thorac Surg 54:810.nSchrader J, Haddy FJ, Gerlach E. 1977. Release of adenosine, inosine and hypoxanthine from the isolated guinea pig heart during hypoxia, flow-autoregulation and reactive hyperemia. Pflugers Arch 369:1-6.nSchubert T, Vetter H, Owen P, et al. 1989. Adenosine cardioplegia. J Thorac Cardiovasc Surg 98:1057-65.nSoderback U, Sollevi A, Fred Holm BB. 1987. The disappearance of adenosine from blood and platelet suspension in relation to platelet cyclic AMP content. Acta Physiol Scand 129:189-94.nTorchiana DF, Vine AJ, Titus JS, et al. 2000. The temperature dependence of cardioplegic distribution in the canine heart. Ann Thorac Surg 70:614-20.nTyers GF, Todd GJ, Niebauer IM. 1975. The mechanism of myocardial damage following potassium citrate (Melrose) cardioplegia. Surgery 78:45-53.nWillem de Jong J, van de Meer P, van Loon H, et al. 1990. Adenosine as adjunct to potassium cardioplegia: effect on function, energy metabolism, and electrophysiology. J Thorac Cardiovasc Surg 100:445-54.nWilson RF, Wyche K, Christensen BV, et al. 1990. Effects of adenosine on human coronary arterial circulation. Circulation 82:1596-606.nBelardinelli L, Giles WR, West A. 1988. Ionic mechanisms of adenosine actions in pacemaker cells from the rabbit heart. J Physiol 405:615-33.nHearse DJ, Stewart DA, Braimbridge MV. 1978. Myocardial protection during ischemic cardiac arrest: possible deleterious effects of glucose and mannitol in coronary infusates. J Thorac Cardiovasc Surg 36:320-7.nLasley RD, Konyn PJ, Hegge JO, et al. 1995. The effects of ischemic and adenosine preconditioning on interstitial fluid adenosine and myocardial infarct size. Am J Physiol 269:H1460-6.nLatouff OM, Jabr AK, Spence PA. 1995. Pitfalls in warm oxygenated blood cardioplegia. In: Salerno TA, ed. Warm heart surgery. London: Edward Arnold Press. p 134-9.nLedingham S, Katayama O, Lachno D, et al. 1990. Beneficial effects of adenosine during reperfusion following prolonged cardioplegic arrest. Cardiovasc Res 24:247-53.nLe Houerou D, Singh AI, Romano M, et al. 1992. Minimal hemodilution and optimal potassium use during normothermic aerobic arrest. Ann Thorac Surg 54:815-6.nLichtenstein SV, Ashe KA, el Dalati HE, et al. 1991. Warm heart surgery. J Thorac Cardiovasc Surg 101:269-74.nLichtenstein SV, Salerno TA, Slutsky AS. 1990. Pro: warm continuous cardioplegia is preferable to intermittent hypothermic cardioplegia for myocardial protection during cardiopulmonary bypass. J Cardiothorac Anesth 4:279-81.nYoneyama F, Aihara K, Kogi K, et al. 1999. Similarity and dissimilarity in mode and mechanism of action between YT-146, a selective adenosine receptor A agonist, and adenosine in isolated canine hearts. Tohoku J Exp Med 188:31-45.n
